A retrospective cohort study for assessing frequency of Idiosyncratic drug-induced liver injury (DILI) caused by oral anticoagulants (OACs) in a population-based setting
Latest Information Update: 09 Jul 2021
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Edoxaban (Primary) ; Rivaroxaban (Primary) ; Warfarin (Primary)
- Indications Thrombosis
- Focus Adverse reactions
- 09 Jul 2021 New trial record